Dr. Brian Labus, Epidemiologist with the UNLV School of Public Health and the governor’s medical advisory team, and RJ Health reporter Mary Hynes cover the latest topics surrounding COVID-19 in Nevada.
Topics this week:
1. SUNDAY’S REPORT: NEVADA HAS DEADLIEST WEEK FROM COVID-19
2. WHY IS TESTING AND RESULTS TAKING SO LONG?
3. VACCINE TRIALS STARTING IN LAS VEGAS
As of May 27, there have been over 100,000 reported deaths related to COVID-19 in the U.S.The pandemic has infected over 1.7 million people in the country. (Las Vegas Review-Journal)
US Begins First Human Trial
of Coronavirus Vaccine.
The first human trial to evaluate a
candidate vaccine against the new
coronavirus has begun in Seattle.
The vaccine, called mRNA-1273, was developed by US National Institutes of Health (NIH) scientists and collaborators in Cambridge, Massachusetts.
The NIH announced the trial will enroll
“45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks.”.
Pharmaceuticals and research labs around the world have raced to develop a treatment to the new coronavirus for which there is currently no vaccine available.
The development is a step in the right direction, though the vaccine must pass more trial phases to prove its effectiveness and safety.
It could be up to 18 months
before it becomes available to the public
The Queen Mary BioEnterprises Innovation Centre in London is seeking two dozen volunteers to inject themselves with coronavirus. Their intention is to help a company called hVIVO find a vaccine for the disease that has killed almost 4,000 people worldwide so far. (Las Vegas Review-Journal)
Doctors are able to gauge what our flu season might look like, based on how bad the flu season was in the southern hemisphere. (Mat Luschek / Review-Journal)
